| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 3,420 | $30 | $112.9K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,680 | $30 | $110.3K |
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 5,420 | $20 | $92.2K |
| J3262 | Injection, tocilizumab, 1 mg | 10,200 | $10 | $51K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 660 | $80 | $50.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 250 | $120 | $29.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 510 | $50 | $26.7K |
| J0897 | Injection, denosumab, 1 mg | 840 | $20 | $16K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 180 | $80 | $15K |
| 83516 | The lab analyst performs the technical immunoassay test involving several steps to detect and measure an analyte of a noninfectious nature. The results show as positive or negative, or in… | 1,350 | $10 | $14.9K |